Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.705 SEK | +1.51% |
|
+0.82% | +19.90% |
May. 21 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.90% | 4.06M | |
+61.22% | 846B | |
+39.68% | 628B | |
-4.66% | 360B | |
+16.77% | 322B | |
+8.50% | 297B | |
+14.47% | 240B | |
+17.92% | 223B | |
+3.15% | 224B | |
+11.68% | 173B |
- Stock Market
- Equities
- ONCOZ Stock
- News OncoZenge AB
- OncoZenge Seeks to Expand Patent Protection for Oral Lozenge Product BupiZenge